Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 196.36 | (77.18) | (12.74)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 304.36 | (18.30) | (4.42)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 436.41 | 99.11 | 4.17¢ | 29.0 | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Geron explains setback on stem cell study | 28-Aug-2009 | BayArea.com |
Geron sees progress in stem-cell therapy | 27-Aug-2007 | BayArea.com |
Stock Ticker | 12-Jun-2007 | BayArea.com |
Currency | US Dollars |
Share Price | $ 1.21 |
Closing Price Change | $ 0.04 |
% Change | 0.00 % |
52 Week High | $4.75 |
52 Week Low | $1.14 |
Volume | 0 |
Shares Issued | 186.46m |
RiskGrade | 277 |
Strong Buy | 3 |
Buy | 3 |
Neutral | 4 |
Sell | 1 |
Strong Sell | 0 |
Total | 11 |
Time | Volume / Share Price |
14:45 | 100 @ $1.23 |
14:45 | 100 @ $1.23 |
14:45 | 100 @ $1.23 |
14:45 | 100 @ $1.23 |
14:45 | 100 @ $1.23 |
You are here: research